Literature DB >> 19528256

Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.

Simona Greco1, Marco De Simone, Claudia Colussi, Germana Zaccagnini, Pasquale Fasanaro, Mario Pescatori, Rosanna Cardani, Riccardo Perbellini, Eleonora Isaia, Patrizio Sale, Giovanni Meola, Maurizio C Capogrossi, Carlo Gaetano, Fabio Martelli.   

Abstract

The aim of this work was to identify micro-RNAs (miRNAs) involved in the pathological pathways activated in skeletal muscle damage and regeneration by both dystrophin absence and acute ischemia. Eleven miRNAs were deregulated both in MDX mice and in Duchenne muscular dystrophy patients (DMD signature). Therapeutic interventions ameliorating the mdx-phenotype rescued DMD-signature alterations. The significance of DMD-signature changes was characterized using a damage/regeneration mouse model of hind-limb ischemia and newborn mice. According to their expression, DMD-signature miRNAs were divided into 3 classes. 1) Regeneration miRNAs, miR-31, miR-34c, miR-206, miR-335, miR-449, and miR-494, which were induced in MDX mice and in DMD patients, but also in newborn mice and in newly formed myofibers during postischemic regeneration. Notably, miR-206, miR-34c, and miR-335 were up-regulated following myoblast differentiation in vitro. 2) Degenerative-miRNAs, miR-1, miR-29c, and miR-135a, that were down-modulated in MDX mice, in DMD patients, in the degenerative phase of the ischemia response, and in newborn mice. Their down-modulation was linked to myofiber loss and fibrosis. 3) Inflammatory miRNAs, miR-222 and miR-223, which were expressed in damaged muscle areas, and their expression correlated with the presence of infiltrating inflammatory cells. These findings show an important role of miRNAs in physiopathological pathways regulating muscle response to damage and regeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528256     DOI: 10.1096/fj.08-128579

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  135 in total

1.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

Review 2.  Fat deposition and accumulation in the damaged and inflamed skeletal muscle: cellular and molecular players.

Authors:  Clara Sciorati; Emilio Clementi; Angelo A Manfredi; Patrizia Rovere-Querini
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

3.  Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy.

Authors:  Junaith S Mohamed; Ameena Hajira; Michael A Lopez; Aladin M Boriek
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

4.  Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training.

Authors:  Aaron P Russell; Severine Lamon; Hanneke Boon; Shogo Wada; Isabelle Güller; Erin L Brown; Alexander V Chibalin; Juleen R Zierath; Rod J Snow; Nigel Stepto; Glenn D Wadley; Takayuki Akimoto
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

5.  S100B protein in skeletal muscle regeneration: regulation of myoblast and macrophage functions.

Authors:  F Riuzzi; S Beccafico; G Sorci; R Donato
Journal:  Eur J Transl Myol       Date:  2016-02-23

Review 6.  MicroRNAs in skeletal myogenesis.

Authors:  Yejing Ge; Jie Chen
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

Review 7.  The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy.

Authors:  Christopher R Sibley; Matthew J A Wood
Journal:  J Mol Med (Berl)       Date:  2011-07-13       Impact factor: 4.599

8.  Alterations in the muscle force transfer apparatus in aged rats during unloading and reloading: impact of microRNA-31.

Authors:  David C Hughes; George R Marcotte; Leslie M Baehr; Daniel W D West; Andrea G Marshall; Scott M Ebert; Arik Davidyan; Christopher M Adams; Sue C Bodine; Keith Baar
Journal:  J Physiol       Date:  2018-07       Impact factor: 5.182

9.  The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.

Authors:  Kamal Razavi-Azarkhiavi; Mahmoud Reza Jaafari; Khalil Abnous; Bibi Marjan Razavi; Amir Hossein Jafarian; Faezeh Vahdati Hassani; Kobra Shirani; Gholamreza Karimi
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

10.  Bta-miR-34b inhibits proliferation and promotes apoptosis via the MEK/ERK pathway by targeting MAP2K1 in bovine primary Sertoli cells.

Authors:  Linlin Zhang; Tiantian Ma; Qibing Tao; Wushuang Tan; Huatao Chen; Wei Liu; Pengfei Lin; Dong Zhou; Aihua Wang; Yaping Jin; Keqiong Tang
Journal:  J Anim Sci       Date:  2020-10-01       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.